Rensselaer’s biotechnology initiative stands at the intersection of the life sciences, the physical and computer sciences, and engineering. In Biotechnology and the Life Sciences, we are creating new routes to drug discovery and development, and understanding the fundamental mechanisms of disease, from Alzheimer's, diabetes, osteoporosis and osteoarthritis, to cancer.
The intersection of life sciences with the physical sciences and engineering fosters advances in biomanufacturing, antimicrobial surfaces and coatings, and bioimaging and regenerative medicine. Our growing cadre of interdisciplinary biotechnology researchers, supported by the world-class infrastructure in the Center for Biotechnology and Interdisciplinary Studies and an increasing level of federal and state funding, are making major discoveries at the intersection of engineering, technology, and the life sciences.
Research Centers, Platforms, and News focusing on Biotechnology and the Life Sciences: